Evaluation of Antibiotic Use Based on ATC/DDD Criteria In Children with Pneumonia at RSI Siti Rahmah Padang
:
Abstract
Pneumonia is inflammation or infection of the respiratory tract which causes pain and makes it difficult for sufferers to breathe because there is fluid in the form of pus in the alveoli sacs. Pneumonia is the highest cause of death in the world, especially in children under 5 years of age. Pneumonia caused by bacterial infections is treated using antibiotics. Antibiotics that are used inappropriately can cause bacterial resistance, resulting in worsening infections, an increase in infections, longer hospital stays, and increased health service costs. The aim of this research is to determine the quantitative evaluation of antibiotic use in pediatric patients with pneumonia at RSI Siti Rahmah Padang. This research is observational analytic with a retrospective design. The samples used in this study were pediatric pneumonia patients aged ≤18 years who cmet the inclusion criteria. Quantitative analysis was carried out by calculating the quantity of antibiotics used by pediatric pneumonia patients based on ATC/DDD criteria. The research results showed that the total DDD was 51.69 DDD/100 patient-days with the highest DDD value for the antibiotic ceftriaxone with a value of 19.44 DDD/100 patient-days.
References
Bestari, M.P., Karuniawati, H., 2019. Evaluasi Rasionalitas dan Efektifitas Penggunaan Antibiotik pada Pasien Pneumonia Pediatrik di Instalasi Rawat Inap Rumah Sakit Pusat Jawa Tengah. Pharmacon J. Farm. Indones. 14, 62–71. https://doi.org/10.23917/pharmacon.v14i2.6524
Damayanti, M., Olivianto, E., Yunita, E.P., 2022. Effects of Rational Use of Antibiotics on Clinical Improvement of Pediatric Inpatients with Pneumonia. Indones. J. Clin. Pharm. 11, 129–144. https://doi.org/10.15416/ijcp.2022.11.2.129
Elvionita, C., Sari, I.P., Nuryastuti, T., 2023. Evaluation the Rationality of Clinical Outcomes of Antibiotic Use and Patterns of Bacterial Resistance to Antibiotics in Children with Pneumonia. Maj. Farm. 19, 131–139. https://doi.org/10.22146/farmaseutik.v19i1.76103
Hudmawan, Z.A., Abdurrahmat, A.S., Annashr, N.N., 2023. Hubungan Antara Faktor Host Dan Environment Dengan Kejadian Pneumonia Pada Balita di Wilayah Kerja UPTD Puskesmas Cilembang Kota Tasikmalaya. J. Kesehat. Komunitas Indones. 19, 127–148. https://doi.org/10.37058/jkki.v19i2.8644
Junaidi, A. kahar, I., Rohana, T., Prijaya, S., Vierto, 2021. Faktor-Faktor yang Berhubungan dengan Kejadian Pneumonia Pada Anak Usia 12-59 Bulan di Wilayah Kerja Puskesmas Padang Rubek Kabupaten Nagan Raya Tahun 2021. J. Healthc. Technol. Med. 7.
KemenKes RI, 2022. Mengenal Apa Itu Pneumonia. Kementerian Kesehatan Republik Indonesia
Koernia Wahidah, L., Tri Wahyuni, N., Maharani Putri, D., 2021. Evaluasi Penggunaan Antibiotik Pneumonia Dengan Metode ATC/DDD Pada Pasien Pediatri di Instalasi Rawat Inap RSUD Dr. A. Dadi Tjokrodipo Bandar Lampung Tahun 2019. JFL Jurnal Farmasi Lampung 9, 99–108. https://doi.org/10.37090/jfl.v9i2.338
Kristanti, W., Virianti, G., Primasanti, D., Erwiani, M., 2022. Antibiotik Pada Pasien Pneumonia di Era Pandemi Covid-19. MEDFARM J. Farm. Dan Kesehatan 11, 16–27.
Maghfiroh, S., Priyanti, R.P., Mubarrok, A.S., 2019. Hubungan waktu tunggu dan length of stay (LOS) Dengan kepuasan pasien di instalasi Gawat darurat rsud jombang. J. Keperawatan Muhammadiyah 4. https://doi.org/10.30651/jkm.v4i1.2200
Manggau, M.A., Djaharuddin, I., 2022. Evaluasi Penggunaan Terapi Antibiotik Empiris Terhadap Luaran Klinis Pasien Pneumonia Komunitas Rawat Inap. Majalah Farmasi dan Farmakologo 26, 19–25.
PDPI, 2022. Outbreak Pneumonia di Tiongkok. Perhimpunan Dokter Paru Indonesia.
Rakhmadi, D., Hariyanto, T., 2018. Perbedaan Lama Hari Rawat Inap Pasien Pneumonia dengan Non Pneumonia di Ruang Perawatan Anak Rumah Sakit Umum Daerah Kotabaru. Nurs. News (Meriden) 3.
Sartika, V., Amalia, L., 2023. Evaluasi Penggunaan Antibiotik Pada Pasien Rawat Inap Anak Bronkopneumonia Di Salah Satu Rumah Sakit Tipe B di Bandung 4.
WHO, 2022. Pneumonia in children. World Health Organization.
Copyright (c) 2024 JOPS (Journal Of Pharmacy and Science)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of all journal manuscripts is held by the JOPS (Journal Of Pharmacy and Science)
2. Formal legal provisions to access digital articles of electronic journal are subject to the provision of the Creative Commons Attribution-ShareAlike license (CC BY-NC-SA), which means that JOPS (Journal Of Pharmacy and Science) is rightful to keep, transfer media/format, manage in the form of databases, maintain, and publish articles.
3. Published manuscripts both printed and electronic are open access for educational, research, and library purposes. Additiponally, the editorial board is not responsible for any violations of copyright law.
licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
PDF (Bahasa Indonesia)
Abstract views: 6
downloads: 11
1.png)
